Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.61 |
| ▸ | ECE1 | P42892 | 13/20 | 0.57 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29492470 | 0.93 | ACE (0.62) | ACEECE1ERAP2ALOX15 | |
| SCHEMBL31039961 | 0.93 | MAGI3 (0.58) | ACEECE1ERAP2 | |
| SCHEMBL11102828 | 0.92 | ACE (0.55) | ACEECE1ERAP2 | |
| SCHEMBL11102835 | 0.92 | ACE (0.55) | ACEECE1ERAP2 | |
| SCHEMBL29696985 | 0.91 | ACE (0.65) | ACEECE1ERAP2ALOX15 | |
| SCHEMBL21641793 | 0.91 | ACE (0.73) | ACEECE1ERAP2ALOX15 | |
| SCHEMBL21641792 | 0.91 | ACE (0.73) | ACEECE1ERAP2ALOX15 | |
| SCHEMBL21641791 | 0.91 | ACE (0.73) | ACEECE1ERAP2ALOX15 | |
| SCHEMBL29380886 | 0.91 | ACE (0.73) | ACEECE1ERAP2ALOX15 | |
| SCHEMBL30465908 | 0.90 | ACE (0.64) | ACEECE1ERAP2ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116970080-B | Anti-human MFAP5 monoclonal antibody and preparation method thereof, polynucleotide molecule, expression vector and host cell | 优睿赛思(武汉)生物科技有限公司 | 2024-08-13 | — | — | CN | disclosed |
| US-20240091375-A1 | AN ANTIBODY FRAGMENT BASED ANTIMICROBIAL CONJUGATE SELECTIVELY TARGETING PSEUDOMONAS | ABGENICS LIFESCIENCES PRIVATE LIMITED (IN) | 2024-03-21 | — | — | US | disclosed |